Epidiolex for Sturge-Weber Syndrome

(Epi-Pre Trial)

This trial examines whether Epidiolex, a form of cannabidiol, can delay seizures in young children with Sturge-Weber syndrome, a rare condition causing skin and brain abnormalities. Seizures can worsen brain outcomes, so the trial aims to determine if starting treatment before seizures begin can make a difference. It focuses on children aged 1 to 18 months who have been diagnosed with Sturge-Weber syndrome but have not yet experienced seizures. Participants should not have severe liver disease or other uncontrolled medical issues. As a Phase 2 trial, the research measures how well the treatment works in an initial, smaller group of people.

Research has shown that Epidiolex, a CBD oral solution, is generally safe for patients. The FDA has already approved Epidiolex to treat seizures in conditions like Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex, indicating thorough testing for these conditions.

In past studies, patients tolerated Epidiolex well, with most side effects being mild to moderate, such as sleepiness, reduced appetite, and diarrhea. Serious side effects were rare.

Epidiolex is unique because it's derived from cannabidiol (CBD), a component of cannabis, which offers a new mechanism of action for treating Sturge-Weber Syndrome. Unlike traditional treatments that primarily focus on controlling seizures with anticonvulsants, Epidiolex targets the endocannabinoid system, potentially offering a different pathway to manage symptoms. Researchers are excited about this treatment because it may provide better seizure control with fewer side effects, thanks to its plant-based origin.

Research has shown that Epidiolex, a type of cannabidiol (CBD), may help reduce seizures in people with Sturge-Weber syndrome (SWS). Studies have found that some patients experienced more than a 50% decrease in seizures after using CBD for several weeks. In this trial, participants will receive presymptomatic Epidiolex treatment to evaluate its potential in managing SWS symptoms and possibly delaying the onset of seizures. Besides controlling seizures, Epidiolex may also enhance quality of life, mood, and brain function. It has demonstrated benefits for neurological and cognitive improvements, even when not directly linked to seizure control.⁶⁷⁸⁹¹⁰